论文部分内容阅读
目的探讨沐舒坦雾化吸入辅助治疗小儿毛细支气管炎的临床疗效。方法随机将120例毛细支气管炎患儿分为治疗组60例和对照组60例。两组患儿均采用常规治疗方法,治疗组在此基础上加用沐舒坦雾化吸入。结果治疗组患儿7d临床治愈率明显高于对照组,发热、咳嗽、喘憋、肺部啰音等消失时间明显短于对照组。结论沐舒坦雾化吸入治疗婴幼儿毛细支气管炎方法简便,疗效显著,无不良反应发生,值得推广应用。
Objective To investigate the clinical efficacy of mucosolvan inhalation in the treatment of infantile bronchiolitis. Methods A total of 120 children with bronchiolitis were randomly divided into treatment group (60 cases) and control group (60 cases). The two groups of children were treated with conventional methods, the treatment group on the basis of the addition of mucosolvan inhalation. Results The clinical cure rate of the treatment group was significantly higher than that of the control group on the 7th day. The disappearance time of fever, cough, wheezing and pulmonary rales was significantly shorter than that of the control group. Conclusion Mucosolvan inhalation is an effective and safe method for the treatment of bronchiolitis in infants and young children with significant curative effect and no adverse reactions. It is worth popularizing and applying.